The genetic architecture of multiple myeloma GJ Morgan, BA Walker, FE Davies Nature Reviews Cancer 12 (5), 335-348, 2012 | 1112 | 2012 |
The chicken B locus is a minimal essential major histocompatibility complex J Kaufman, S Milne, TWF Göbel, BA Walker, JP Jacob, C Auffray, ... Nature 401 (6756), 923-925, 1999 | 773 | 1999 |
Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma BA Walker, EM Boyle, CP Wardell, A Murison, DB Begum, NM Dahir, ... Journal of clinical oncology 33 (33), 3911-3920, 2015 | 634 | 2015 |
A genetic variation map for chicken with 2.8 million single-nucleotide polymorphisms Genome sequence of red jungle fowl: Washington University School of Medicine ... Nature 432 (7018), 717-722, 2004 | 626 | 2004 |
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value BA Walker, PE Leone, L Chiecchio, NJ Dickens, MW Jenner, KD Boyd, ... Blood, The Journal of the American Society of Hematology 116 (15), e56-e65, 2010 | 460 | 2010 |
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma BA Walker, K Mavrommatis, CP Wardell, TC Ashby, M Bauer, FE Davies, ... Blood, The Journal of the American Society of Hematology 132 (6), 587-597, 2018 | 424 | 2018 |
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial KD Boyd, FM Ross, L Chiecchio, GP Dagrada, ZJ Konn, WJ Tapper, ... Leukemia 26 (2), 349-355, 2012 | 421 | 2012 |
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis BA Walker, K Mavrommatis, CP Wardell, TC Ashby, M Bauer, F Davies, ... Leukemia 33 (1), 159-170, 2019 | 420 | 2019 |
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing L Rasche, SS Chavan, OW Stephens, PH Patel, R Tytarenko, C Ashby, ... Nature communications 8 (1), 268, 2017 | 362 | 2017 |
APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma BA Walker, CP Wardell, A Murison, EM Boyle, DB Begum, NM Dahir, ... Nature communications 6 (1), 6997, 2015 | 347 | 2015 |
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms BA Walker, CP Wardell, L Melchor, A Brioli, DC Johnson, MF Kaiser, ... Leukemia 28 (2), 384-390, 2014 | 345 | 2014 |
Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma BA Walker, CP Wardell, L Chiecchio, EM Smith, KD Boyd, A Neri, ... Blood, The Journal of the American Society of Hematology 117 (2), 553-562, 2011 | 318 | 2011 |
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t (4; 14) and t (11; 14) myeloma BA Walker, CP Wardell, L Melchor, S Hulkki, NE Potter, DC Johnson, ... Blood, The Journal of the American Society of Hematology 120 (5), 1077-1086, 2012 | 313 | 2012 |
Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma L Melchor, A Brioli, CP Wardell, A Murison, NE Potter, MF Kaiser, ... Leukemia 28 (8), 1705-1715, 2014 | 286 | 2014 |
Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients V Shah, AL Sherborne, BA Walker, DC Johnson, EM Boyle, S Ellis, ... Leukemia 32 (1), 102-110, 2018 | 241 | 2018 |
Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma BA Walker, PE Leone, MW Jenner, C Li, D Gonzalez, DC Johnson, ... Blood 108 (5), 1733-1743, 2006 | 230 | 2006 |
Mapping of Chromosome 1p Deletions in Myeloma Identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as Being Genes in Regions Associated with Adverse Survival KD Boyd, FM Ross, BA Walker, CP Wardell, WJ Tapper, L Chiecchio, ... Clinical cancer research 17 (24), 7776-7784, 2011 | 227 | 2011 |
Low expression of hexokinase-2 is associated with false-negative FDG–positron emission tomography in multiple myeloma L Rasche, E Angtuaco, JE McDonald, A Buros, C Stein, C Pawlyn, ... Blood, The Journal of the American Society of Hematology 130 (1), 30-34, 2017 | 219 | 2017 |
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma N Weinhold, C Ashby, L Rasche, SS Chavan, C Stein, OW Stephens, ... Blood, The Journal of the American Society of Hematology 128 (13), 1735-1744, 2016 | 215 | 2016 |
Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients BA Walker, CP Wardell, A Brioli, E Boyle, MF Kaiser, DB Begum, NB Dahir, ... Blood cancer journal 4 (3), e191-e191, 2014 | 215 | 2014 |